Actively Recruiting
Study of Advanced Practice Nurse Involvement in Managing Chronic Myeloid Leukemia Patients Compared to Standard Hematologist Care
Led by Centre Hospitalier Henri Duffaut - Avignon · Updated on 2026-03-04
60
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Chronic Myeloid Leukemia CML affects many people, especially those over 60 years old. This research evaluates how Advanced Practice Nurses APN can help manage patients with CML by detecting and managing mild to moderate side effects early, improving quality of life, treatment compliance, and therapeutic outcomes. The study compares care led by APNs alongside hematologists versus standard care with hematologists alone. Participants are randomly assigned to one of two groups one group receives follow-up care from both an APN and a hematologist, while the other group is managed by a hematologist only. The study uses questionnaires to assess quality of life and treatment adherence. Care focuses on early detection and management of grade I-II adverse events, with follow-up visits occurring from inclusion up to 12 months. During the study, patients complete quality of life and compliance assessments at inclusion and at 6 and 12 months. Researchers track adverse events, hospitalizations, treatment changes, consultation times, and molecular response rates. The primary outcome is the APNs role in early detection of adverse events within 6 months. Safety and treatment effects are monitored throughout the 12-month study period.
CONDITIONS
Brief Title
Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia
Research Team
M
Marilyne Grinand, PhD
C
Christine Tosello, APN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here